Combination of bolus 5-fluorouracil, folinic acid and mitomycin C in advanced gastric cancer: results of a phase II trial
Background: Gastric carcinoma still is a worldwide major cause of cancer death. Although various chemotherapy schedules yielded high response rates, median survival rarely exceeds 8-10 months. Many regimens are inevitably associated with significant toxicity which jeopardizes their value as palliati...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
October 2000
|
| In: |
Onkologie
Year: 2000, Volume: 23, Issue: 5, Pages: 444-447 |
| ISSN: | 1423-0240 |
| DOI: | 10.1159/000027215 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1159/000027215 Verlag, lizenzpflichtig, Volltext: https://www.karger.com/Article/FullText/27215 
|
| Author Notes: | G. Hartung, R. Hofheinz, D. Buchheidt, A. Rost, A. Brecht, K. Forche, M. Schröder, C. Wojatschek, D. Fritze, R. Hehlmann, W. Queisser |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1802591087 | ||
| 003 | DE-627 | ||
| 005 | 20230428182442.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220519s2000 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1159/000027215 |2 doi | |
| 035 | |a (DE-627)1802591087 | ||
| 035 | |a (DE-599)KXP1802591087 | ||
| 035 | |a (OCoLC)1341460209 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Hartung, Gernot |e VerfasserIn |0 (DE-588)1066874409 |0 (DE-627)817992111 |0 (DE-576)426256050 |4 aut | |
| 245 | 1 | 0 | |a Combination of bolus 5-fluorouracil, folinic acid and mitomycin C in advanced gastric cancer |b results of a phase II trial |c G. Hartung, R. Hofheinz, D. Buchheidt, A. Rost, A. Brecht, K. Forche, M. Schröder, C. Wojatschek, D. Fritze, R. Hehlmann, W. Queisser |
| 264 | 1 | |c October 2000 | |
| 300 | |a 4 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 19.05.2022 | ||
| 520 | |a Background: Gastric carcinoma still is a worldwide major cause of cancer death. Although various chemotherapy schedules yielded high response rates, median survival rarely exceeds 8-10 months. Many regimens are inevitably associated with significant toxicity which jeopardizes their value as palliative treatment, especially in patients with reduced performances status. Therefore, we initiated a phase II study for the treatment of advanced gastric carcinoma using a bolus regimen with mitomycin C (MMC), 5-fluorouracil (5-FU) and folinic acid (FA), allowing the enrollment of elderly patients or those with reduced performance status (WHO grade 2). Patients and Methods: Between 1996 and 1998 we recruited a total of 58 patients with advanced gastric cancer to receive bolus MMC 3 mg/m2, 5-FU 450 mg/m2, and FA 100 mg/m2 on days 1-3. Treatment was repeated on day 22. 53 patients met the inclusion criteria: male n = 36, female n =17; median age 65 (range 26-81); mean WHO status 1 (range 0-2). Results: Out of 53 patients 50 were evaluable for response, all 58 patients who received therapy were evaluable for toxicity. Eleven patients (22%) achieved partial remission (95% CI: 11.5 -36.0%), 24 (48%) no change and 15 (30%) were progressive. Median overall survival was 11.5 months, the median time to progression 6.0 months. Out of 290 treatment cycles the worst toxicities observed (WHO 2/3/4) were as follows: anemia 13/3/1, leukopenia 19/1/1, thrombopenia 11/3/0, nausea/emesis 11/2/0, infections 2/1/0, diarrhea 14/2/0, and stomatitis 6/1/1. One patient developed hemolytic-uremic syndrome. Conclusions: The tumor control rate (PR + NC) of 70% was comparable to established chemotherapy regimens, while median overall survival was promising. Toxicity was mild, allowing the treatment especially for elderly patients and on outpatient basis. | ||
| 700 | 1 | |a Hofheinz, Ralf-Dieter |d 1969- |e VerfasserIn |0 (DE-588)121917517 |0 (DE-627)08161876X |0 (DE-576)292991568 |4 aut | |
| 700 | 1 | |a Buchheidt, Dieter |d 1955- |e VerfasserIn |0 (DE-588)1028287461 |0 (DE-627)730538621 |0 (DE-576)375787380 |4 aut | |
| 700 | 1 | |a Rost, A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Brecht, A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Forche, K. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schröder, M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Wojatschek, C. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Fritze, D. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hehlmann, Rüdiger |d 1941- |e VerfasserIn |0 (DE-588)1037003489 |0 (DE-627)751737879 |0 (DE-576)390939463 |4 aut | |
| 700 | 1 | |a Queißer, Wolfgang |d 1936- |e VerfasserIn |0 (DE-588)115699325 |0 (DE-627)077414225 |0 (DE-576)162635923 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Onkologie |d Basel : Karger, 1978 |g 23(2000), 5, Seite 444-447 |h Online-Ressource |w (DE-627)300595417 |w (DE-600)1483097-8 |w (DE-576)105282863 |x 1423-0240 |7 nnas |a Combination of bolus 5-fluorouracil, folinic acid and mitomycin C in advanced gastric cancer results of a phase II trial |
| 773 | 1 | 8 | |g volume:23 |g year:2000 |g number:5 |g pages:444-447 |g extent:4 |a Combination of bolus 5-fluorouracil, folinic acid and mitomycin C in advanced gastric cancer results of a phase II trial |
| 856 | 4 | 0 | |u https://doi.org/10.1159/000027215 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.karger.com/Article/FullText/27215 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20220519 | ||
| 993 | |a Article | ||
| 994 | |a 2000 | ||
| 998 | |g 115699325 |a Queißer, Wolfgang |m 115699325:Queißer, Wolfgang |d 60000 |d 61200 |e 60000PQ115699325 |e 61200PQ115699325 |k 0/60000/ |k 1/60000/61200/ |p 11 |y j | ||
| 998 | |g 1037003489 |a Hehlmann, Rüdiger |m 1037003489:Hehlmann, Rüdiger |d 60000 |d 61200 |e 60000PH1037003489 |e 61200PH1037003489 |k 0/60000/ |k 1/60000/61200/ |p 10 | ||
| 998 | |g 1028287461 |a Buchheidt, Dieter |m 1028287461:Buchheidt, Dieter |d 60000 |d 61200 |e 60000PB1028287461 |e 61200PB1028287461 |k 0/60000/ |k 1/60000/61200/ |p 3 | ||
| 998 | |g 121917517 |a Hofheinz, Ralf-Dieter |m 121917517:Hofheinz, Ralf-Dieter |d 60000 |d 61200 |e 60000PH121917517 |e 61200PH121917517 |k 0/60000/ |k 1/60000/61200/ |p 2 | ||
| 999 | |a KXP-PPN1802591087 |e 4136162553 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"origin":[{"dateIssuedDisp":"October 2000","dateIssuedKey":"2000"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"relHost":[{"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"publisherPlace":"Basel","dateIssuedKey":"1978","dateIssuedDisp":"1978-2013","publisher":"Karger"}],"language":["ger"],"physDesc":[{"extent":"Online-Ressource"}],"part":{"text":"23(2000), 5, Seite 444-447","issue":"5","volume":"23","year":"2000","extent":"4","pages":"444-447"},"note":["Gesehen am 15.12.2023"],"disp":"Combination of bolus 5-fluorouracil, folinic acid and mitomycin C in advanced gastric cancer results of a phase II trialOnkologie","title":[{"title":"Onkologie","title_sort":"Onkologie","subtitle":"international journal for cancer research and treatment"}],"id":{"issn":["1423-0240"],"zdb":["1483097-8"],"eki":["300595417"]},"recId":"300595417","pubHistory":["1.1978 - 36.2013"]}],"person":[{"family":"Hartung","roleDisplay":"VerfasserIn","given":"Gernot","role":"aut","display":"Hartung, Gernot"},{"family":"Hofheinz","roleDisplay":"VerfasserIn","given":"Ralf-Dieter","display":"Hofheinz, Ralf-Dieter","role":"aut"},{"roleDisplay":"VerfasserIn","family":"Buchheidt","given":"Dieter","role":"aut","display":"Buchheidt, Dieter"},{"roleDisplay":"VerfasserIn","family":"Rost","given":"A.","display":"Rost, A.","role":"aut"},{"given":"A.","role":"aut","display":"Brecht, A.","roleDisplay":"VerfasserIn","family":"Brecht"},{"given":"K.","role":"aut","display":"Forche, K.","family":"Forche","roleDisplay":"VerfasserIn"},{"family":"Schröder","roleDisplay":"VerfasserIn","display":"Schröder, M.","role":"aut","given":"M."},{"family":"Wojatschek","roleDisplay":"VerfasserIn","display":"Wojatschek, C.","role":"aut","given":"C."},{"roleDisplay":"VerfasserIn","family":"Fritze","display":"Fritze, D.","role":"aut","given":"D."},{"role":"aut","display":"Hehlmann, Rüdiger","given":"Rüdiger","roleDisplay":"VerfasserIn","family":"Hehlmann"},{"roleDisplay":"VerfasserIn","family":"Queißer","display":"Queißer, Wolfgang","role":"aut","given":"Wolfgang"}],"physDesc":[{"extent":"4 S."}],"name":{"displayForm":["G. Hartung, R. Hofheinz, D. Buchheidt, A. Rost, A. Brecht, K. Forche, M. Schröder, C. Wojatschek, D. Fritze, R. Hehlmann, W. Queisser"]},"note":["Gesehen am 19.05.2022"],"id":{"doi":["10.1159/000027215"],"eki":["1802591087"]},"title":[{"title":"Combination of bolus 5-fluorouracil, folinic acid and mitomycin C in advanced gastric cancer","title_sort":"Combination of bolus 5-fluorouracil, folinic acid and mitomycin C in advanced gastric cancer","subtitle":"results of a phase II trial"}],"recId":"1802591087"} | ||
| SRT | |a HARTUNGGERCOMBINATIO2000 | ||